Compounds > hydroxychloroquine

hydroxychloroquine and lys01

hydroxychloroquine has been researched along with lys01 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Amaravadi, RK; Davis, LE; Levi, SM; Lynch, JP; Ma, XH; McAfee, Q; Piao, S; Samanta, A; Sepulveda, AR; Uehara, T; Winkler, JD; Zhang, Z1
Amaravadi, RK; Winkler, JD1
Das, S; Duval, DL; Gustafson, DL; Towers, CG; Van Eaton, KM; Viola, LO1

Other Studies

3 other study(ies) available for hydroxychloroquine and lys01

ArticleYear
Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, May-22, Volume: 109, Issue:21

    Topics: Adenocarcinoma; Aminoquinolines; Animals; Antimalarials; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Brain Neoplasms; Carrier Proteins; Cell Death; Colonic Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; HT29 Cells; Humans; Hydroxychloroquine; Intestinal Obstruction; Lysosomes; Mice; Mice, Nude; Polyamines; Xenograft Model Antitumor Assays

2012
Lys05: a new lysosomal autophagy inhibitor.
    Autophagy, 2012, Volume: 8, Issue:9

    Topics: Aminoquinolines; Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Humans; Hydroxychloroquine; Inhibitory Concentration 50; Lysosomes; Mice; Polyamines; Xenograft Model Antitumor Assays

2012
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.
    Veterinary and comparative oncology, 2023, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Dog Diseases; Dogs; Humans; Hydroxychloroquine; Osteosarcoma; RNA, Guide, CRISPR-Cas Systems

2023